Delivering high-quality clinical research services in Eastern Europe since 2005
Clinical Study Design
Consulting and Regulatory Support
Medical writing
Pharmacovigilance Services
Project Management and Monitoring
Data Management and Statistics
Marketing Authorization
GMP InspectionSupport
Since 2005, we have conducted hundreds of clinical trials in Russia and all of Eastern Europe. Our full range of CRO services has helped sponsors worldwide in offshoring their clinical trials and bringing their innovative treatments to market.
Thorough local expertise
• 14+ years’ experience facilitating clinical trials in Russia and Europe • Risk-management approach • 300+ clinical studies in portfolio • Team of 200+ clinical operations professionals
Global sponsors
• Extensive project portfolio with sponsors from EU, US, CIS and Asia • Successfully passed more than 60 audits by sponsors with no significant findings
Record-setting patient enrollment
• Access to the network of 1600+ leading scientific sites • Extensive experience in fast enrollment of patients with different indications • Patient engagement solutions • CRO site management services
Quality
• FDA/EMA acceptable data • Compliance with the international standards (ICH GCP), local regulatory requirements and internal SOPs
30
Aug
Why Russia is among the hottest clinical trials destinations
Irina Petrova, Director of Clinical Operations for OCT Clinical Trials, elaborated on why foreign sponsors choose Russia as a clinical research arena in her article for Applied Clinical Trials.
OCT APPLIED FOR REGULATORY APPROVAL FOR A STUDY IN PATIENTS WITH INFECTION DISEASES
This is a multicenter, randomized, double-blind, placebo-controlled study, which is aimed to evaluate the efficacy and safety of a drug for treatment of acute viral respiratory infections and flu in adults vs. placebo.
22
16
700 Patients Recruited for Ph3 Erectile Dysfunction Study for Futura Medical
OCT, Eastern Europe’s leading CRO, partners with UK-based Futura Medical; completes clinical trial enrolment for MED2002, a topical gel developed to treat erectile dysfunction.
FIRST PATIENTS HAVE BEEN ENROLLED IN TWO CLINICAL STUDIES IN HEMORRHOIDS
OCT has successfully initiated patient recruitment for the phase III clinical trials in hemorrhoids in Russia. Within the project OCT will be running two studies: one with the suppository therapy, and the other where the subjects will undergo a rectal cream treatment. As of now, first subjects have been enrolled in both trials.
15
Jul
11-13
November 2019
BIO-Europe Hamburg
Hamburg, Germany
18-19
September 2019
KoNECT International Conference
Conrad Seoul, South Korea
11-12
BioPharm America 2019
Boston, USA
11
Nov
Schedule a meeting with our Business Development team Polina Shatrova pshatrova@oct-clinicaltrials.com
18
Sep
Schedule a meeting with our Business Development team Olga Ivanova oivanova@oct-clinicaltrials.com
Schedule a meeting with our Business Development team Anna Yanaeva ayanaeva@oct-clinicaltrials.com
* - Required fields
